Pliant Therapeutics (PLRX) Interest Coverage Ratio (2019 - 2026)
Pliant Therapeutics (PLRX) posted quarterly Interest Coverage Ratio of 0.58 for Q1 2026, up 99.21% year-over-year from 0.29 in Q1 2025, and up 92.22% quarter-over-quarter from 7.51 in Q4 2025.
Pliant Therapeutics (PLRX) Interest Coverage Ratio (2019 - 2026) Analysis & Trends
Pliant Therapeutics (PLRX) has reported Interest Coverage Ratio for 8 consecutive years, with 0.58 the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest Coverage Ratio rose 99.21% year-over-year to 0.58; the TTM figure through Mar 2026 stood at 3.2 (up 94.94% YoY), while the FY2025 annual figure was 0.68, up 40.79% from the prior year.
- Interest Coverage Ratio improved to 0.58 in Q1 2026 per PLRX's latest filing, from 7.51 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 34.0 in Q4 2022 and bottomed at 150.43 in Q3 2023.
- Historically, Interest Coverage Ratio has averaged 73.89 across 5 years, with a median of 70.71 in 2024.
- Annual changes were most pronounced in 2023 — Interest Coverage Ratio sank 530.98% — and 2026, when it soared 99.21%.
- Pliant Therapeutics' Interest Coverage Ratio stood at 34.0 in 2022, then tumbled by 530.98% to 146.53 in 2023, then jumped by 69.01% to 45.42 in 2024, then soared by 83.46% to 7.51 in 2025, then jumped by 92.22% to 0.58 in 2026.
- Business Quant data shows PLRX's Interest Coverage Ratio at 0.58 in Q1 2026, 7.51 in Q4 2025, and 34.69 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.66 Bn | 131.80 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.52 Bn | 78.53 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 65.33 Bn | 60.14 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.76 Bn | 54.62 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.15 Bn | 37.05 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.84 Bn | 28.53 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.23 Bn | 9.84 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.52 Bn | 26.36 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.29 Bn | 26.46 Bn | - | 1.42 |
| 10 | Pliant Therapeutics | 71.52 Mn | 71.52 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.58 |
| Dec 31, 2025 | -7.51 |
| Sep 30, 2025 | -34.69 |
| Jun 30, 2025 | -1.12 |
| Mar 31, 2025 | -73.67 |
| Dec 31, 2024 | -45.42 |
| Sep 30, 2024 | -70.71 |
| Jun 30, 2024 | -69.86 |
| Mar 31, 2024 | -104.57 |
| Dec 31, 2023 | -146.53 |
| Sep 30, 2023 | -150.43 |
| Jun 30, 2023 | -148.36 |
| Mar 31, 2023 | -135.35 |
| Dec 31, 2022 | 34.00 |
| Sep 30, 2022 | -106.14 |
| Jun 30, 2022 | -148.21 |
| Mar 31, 2022 | -47.02 |
| Dec 31, 2021 | 18.92 |
| Sep 30, 2021 | -271.13 |
| Jun 30, 2021 | -114.52 |